pharmacology cns depressant
TRANSCRIPT
-
7/29/2019 pharmacology CNS depressant
1/31
Central Nervous System
Depressants
-
7/29/2019 pharmacology CNS depressant
2/31
CNS Depressants
Sedatives
Drugs that have an inhibitory effect on theCNS to the degree that they reduce:
Nervousness
Excitability
Irritability
without causing sleep
-
7/29/2019 pharmacology CNS depressant
3/31
CNS Depressants
Hypnotics
Calm or soothe the CNS to the point that theycause sleep
-
7/29/2019 pharmacology CNS depressant
4/31
CNS Depressants
Sedative-Hypnoticsdose dependent:
At low doses, calm or soothe the CNSwithout inducing sleep
At high doses, calm or soothe the CNS
to the point of causing sleep
-
7/29/2019 pharmacology CNS depressant
5/31
Sedative-Hypnotics:
Barbiturates
First introduced in 1903, standard agentsfor insomnia and sedation
Habit-forming
Only a handful commonly used today duein part to the safety and efficacy of:BENZODIAZEPINES
-
7/29/2019 pharmacology CNS depressant
6/31
Sedative-Hypnotics:
Barbiturates
Four categories:
Ultrashort
mephobexital, thiamylal, thiopentalShort
pentobarbital, secobarbital
Intermediate
aprobarbital, butabarbital,amobarbital
Long
Phenobarbital,mephobarbital
-
7/29/2019 pharmacology CNS depressant
7/31
Sedative-Hypnotics:
Barbiturates
Barbiturates have a very narrow therapeuticindex.
Therapeutic IndexDosage range within which the drug is effectivebut above which is rapidly toxic.
-
7/29/2019 pharmacology CNS depressant
8/31
Sedative-Hypnotics:
Barbiturates
Mechanism of Action
Site of action:
Brain stem (reticular formation)
Cerebral cortex
By inhibiting GABA, nerve impulses traveling inthe cerebral cortex are also inhibited.
-
7/29/2019 pharmacology CNS depressant
9/31
-
7/29/2019 pharmacology CNS depressant
10/31
Barbiturates and benzodiazepines actsimilarly to produce depression of centralnervous system function and behavior.
Both classes of drugs enhance the abilityof the inhibitory neurotransmitter,gamma aminobutyric acid (GABA), toactivate a type of receptors known as
GABA-A receptors. These drugs increasethe effectiveness of GABA by altering thereceptor so that GABA can bind more
easily, an effect known as allostericregulation. Activation of the GABA-Areceptor opens an ion channel, allowingnegatively charged chloride ions to enter
the cell, producing an inhibition of
http://www2.csusm.edu/DandB/GABA.htmlhttp://www2.csusm.edu/DandB/GABA.html -
7/29/2019 pharmacology CNS depressant
11/31
GABA is the main inhibitory neurotransmitter
in the central nervous system (CNS)..
-
7/29/2019 pharmacology CNS depressant
12/31
Sedative-Hypnotics:
Barbiturates
Drug Effects
Low doses: Sedative effects
High doses: Hypnotic effects(also lowers respiratory rate)
-
7/29/2019 pharmacology CNS depressant
13/31
Sedative-Hypnotics:
Barbiturates
Therapeutic Uses
Hypnotics
Sedatives
Anticonvulsants
Surgical procedures
-
7/29/2019 pharmacology CNS depressant
14/31
Sedative-Hypnotics:
Barbiturates
Side Effects
Body System Effects
CNS Drowsiness, lethargy, vertigomental depression, coma
Respiratory Respiratory depression, apnea,
bronchospasms, cough
-
7/29/2019 pharmacology CNS depressant
15/31
Sedative-Hypnotics:
Barbiturates
Side Effects
Body System Effects
GI Nausea, vomiting, diarrhea
Other Agranulocytosis,vasodilation, hypotension,
Stevens-Johnson syndrome
-
7/29/2019 pharmacology CNS depressant
16/31
Sedative-Hypnotics:
Barbiturates
Toxicology
Overdose frequently leads to respiratorydepression, and subsequently,
respiratory arrest.Can be therapeutic:
Anesthesia induction
Uncontrollable seizures: phenobarbitalcoma
-
7/29/2019 pharmacology CNS depressant
17/31
Sedative-Hypnotics:
Barbiturates
Drug InteractionsAdditive effects:
antihistamines, benzodiazepines,
narcotics, tranquilizersInhibited metabolism:
MAOIs will prolong effects ofbarbiturates
Increased metabolism:
Reduces anticoagulant response,leading to possible clot formation
-
7/29/2019 pharmacology CNS depressant
18/31
CNS Depressants:
Benzodiazepines
Most frequently prescribed sedative-hypnotics
Most commonly prescribed drug classes
Favorable side effects
Efficacy
Safety
-
7/29/2019 pharmacology CNS depressant
19/31
CNS Depressants:
BenzodiazepinesClassified as either:Sedative-hypnotic or Anxiolytic
(Medication that relieves anxiety)
-
7/29/2019 pharmacology CNS depressant
20/31
CNS Depressants:
Benzodiazepines
Sedative-Hypnotic Type
Long-Acting:
flurazepam (Dalmane), quazepam
(Doral)
Intermediate:
temazepam (Restoril),
estazolam (Prosom),
Short-Acting:
triazolam (Halcion)
-
7/29/2019 pharmacology CNS depressant
21/31
CNS Depressants:
Benzodiazepines
Anxiolytic Type
alprazolam (Xanax)
chloridiazepoxide (Librium)diazepam (Valium)
lorazepam (Ativan)
midazolam (Versed)
zolpidem (Ambien) and zaleplon (Sonata)
(nonbenzodiazepine hypnotic agents, share characteristics)
-
7/29/2019 pharmacology CNS depressant
22/31
Miscellaneous sedative-hypnotic
agents
chloral hydrate
dexmedetomidine
diphenhydraminedoxylamine
eszopiclone
CNS D
-
7/29/2019 pharmacology CNS depressant
23/31
CNS Depressants:
Benzodiazepines
Mechanism of Action
Depress CNS activity
Affect hypothalamic, thalamic, and limbic
systems of the brain
Benzodiazepine receptors
CNS D
-
7/29/2019 pharmacology CNS depressant
24/31
CNS Depressants:
Benzodiazepines
Drug Effects
Calming effect on the CNS
Useful in controlling agitation andanxiety
CNS D t
-
7/29/2019 pharmacology CNS depressant
25/31
CNS Depressants:
Benzodiazepines
Therapeutic UsesSedation
Sleep induction
Skeletal muscle relaxationAnxiety relief
Treatment of alcohol withdrawal
Agitation
Depression
Epilepsy
Balanced anesthesia
CNS D t
-
7/29/2019 pharmacology CNS depressant
26/31
CNS Depressants:
Benzodiazepines
Side Effects
Mild and infrequent
Headache DrowsinessDizziness VertigoLethargy
Paradoxical excitement(nervousness) Hangover
effect
-
7/29/2019 pharmacology CNS depressant
27/31
CNS Depressants:
Nursing Implications
Before beginning therapy, perform athorough history regarding allergies, useof other medications,health history, and
medical history.Obtain baseline vital signs and I & O,including supine and erect BPs.
Assess for potential disorders orconditions that may be contraindications,and for potential drug interactions.
-
7/29/2019 pharmacology CNS depressant
28/31
CNS Depressants:
Nursing Implications
Give 15 to 30 minutes beforebedtime for maximum effectivenessin inducing sleep.
Most benzodiazepines (exceptflurazepam) cause REM rebound anda tired feeling the next day; use with
caution in the elderly.Patients should be instructed toavoid alcohol and other CNS
depressants.
-
7/29/2019 pharmacology CNS depressant
29/31
CNS Depressants:
Nursing Implications
Check with physician before takingany other medications, including OTCmedications.
It may take 2 to 3 weeks to noticeimproved sleep when takingbarbiturates.
Abruptly stopping these medications,especially barbiturates, may causerebound insomnia.
-
7/29/2019 pharmacology CNS depressant
30/31
CNS Depressants:
Nursing Implications
Safety is important
Keep side rails up
Do not permit smoking
Assist patient with ambulation(especially the elderly)
Keep call light within reach
Monitor for side effects
-
7/29/2019 pharmacology CNS depressant
31/31
CNS Depressants:
Nursing Implications
Monitor for therapeutic effects
Increased ability to sleep at night
Fewer awakenings
Shorter sleep induction time
Few side effects, such as hangovereffects
Improved sense of well-being becauseof improved sleep